A Two-Single-Nucleotide Polymorphism Haplotype in Promoter Region of CYP11B2 Gene Affects Plasma Aldosterone Concentration

A Matched Case-Control Study

Authors

  • Azim Nejatizadeh ardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Keywords:

CYP11B2, Genetic polymorphism, Haplotype, PAC

Abstract

Background: Aldosterone synthesized by aldosterone synthase plays an imperative role in Renin-Angiotensin-Aldosterone System (RAAS). Evidence suggested that aldosterone synthase gene (CYP11B2) variants are associated with the Essential Hypertension (EH).  Objective: The aim of the present study was to determine the association of -344T/C and -470C/T Single Nucleotide Polymorphisms (SNPs) of the CYP11B2 and their resulted haplotypes with EH and Plasma Aldosterone Concentration (PAC) in southern population of Iran.  Methods: In this matched case-control study performed on southern Iranians, 45 patients with EH as well as 43 age- and sex-matched normotensive subjects were registered from September 2017 to September 2018. All the individuals were screened by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) for CYP11B2 related genotypes and haplotypes; PAC was also measured. The gathered data were then analyzed using SPSS16 software by the independent-samples t-test and chi-square test.  Deviations of genotype frequencies from Hardy-Weinberg Equilibrium (HWE) and differences between allele frequencies and genotype distributions were calculated by Chi-square test. For performing haplotype analysis and pairwise Linkage Disequilibrium (LD) among the genotypes, SNP analyzer version 2 software and SHEsis online server were utilized. The association of PAC with each one of the polymorphisms and haplotypes was also analyzed by multinomial logistic regression. Results: There was no association among -344T/C and -470C/T variants and the susceptibility to EH (p=0.53, OR=0.72 and p=0.27, OR=1.69, respectively). Haplotype analysis has also found no association with the disease (CT: p=0.43, OR=1.26; TC: p=0.68, OR=0.88; and TT: p=0.56, OR=0.77). On the other hand, although -344T/C and -470C/T polymorphisms showed no association with PAC (p=0.97, OR=1.00 and p=0.70, OR=0.98, respectively), a significant relationship was found between the H3 haplotype (TT) and PAC (p=0.039, OR=1.29).  Conclusion: Our findings indicated that TT, as the two-single-nucleotide polymorphism haplotype in promoter region of CYP11B2 gene, is associated with plasma aldosterone concentration in the southern population of Iran. So, these people are likely to be at higher risk of cardiovascular or kidney disease compared to the other investigated haplotypes.

References

Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014; 27(11):1355-61. doi: 10.1093/ajh/hpu053, PMid: 24698853, PMCid: PMC4263934 2)Messerli FH, Williams B, Ritz E. Essential hypertension. The Lancet. 2007;370(9587):591-603. doi: 10.1016/S0140-6736(07)61299-9 3)Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlationwith stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ open. 2013;3(8):e003423. doi: 10.1136/bmjopen-2013-003423, PMid: 23996822, PMCid: PMC3758966 4)WHO. Cardiovascular disease: WHO; 2017. Available from: http://www.who.int/cardiovascular_diseases 5)JE H. Guyton and Hall Textbook of Medical Physiology: ELSEVIER; 2012. 6)Kasko M, Budaj M, Hulin I. Harmful or helpful hypertension–pathophysiological basis. Genetics and Pathophysiology of Essential Hypertension. 2012:6-10. doi: 10.5772/30658 7)Ji L, Cai X, Zhang L, Fei L, Wang L, Su J, et al. Association between polymorphisms in the renin-angiotensin-aldosterone system genes and essential hypertension in the Han Chinese population. PloS one. 2013;8(8):e72701. doi: 10.1371/journal.pone.0072701, PMid: 24015270, PMCid: PMC3756014 8)Jiang X, Sheng H, Li J, Xun P, Cheng Y, Huang J, et al. Association between renin–angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens. 2009;23(3):176. doi: 10.1038/jhh.2008.123, PMid: 18830250 9)Mopidevi B, Kaw MK, Puri N, Ponnala M, Jain S, Rana A, et al. Variable transcriptional regulation of the human aldosterone synthase gene causes salt-dependent high blood pressure in transgenic mice. Circulation: Cardiovascular Genetics. 2015;8(1):30-9. doi: 10.1161/CIRCGENETICS.114.000694, PMid: 25504670, PMCid: PMC4334713 10)Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol. 2010;6(5):261. doi: 10.1038/nrneph.2010.30, PMid: 20234356 11)Li N, Li J, Ding Y, Yu T, Shen Y, Fu Q, et al. Novel mutations in the CYP11B2 gene causing aldosteronesynthase deficiency. Molecular Medicine Reports. 2016;13(4):3127-32. doi: 10.3892/mmr.2016.4906, PMid: 26936515 12)Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25(6):947-70. doi: 10.1210/er.2003-0030, PMid: 15583024 13)Tanahashi H, Mune T, Takahashi Y, Isaji M, Suwa T, Morita H, et al. Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas. The J Clin Endocrinol Metab. 2005;90(11):6226-31. doi: 10.1210/jc.2005-0299, PMid: 16118341 14)Niu W, Guo S, Zhang Y, Gao P, Zhu D. Genetic and functional analyses of aldosterone synthase gene C-344T polymorphism with essential hypertension. J Hum Hypertens. 2010;24(6):427. doi: 10.1038/jhh.2010.12, PMid: 20182453 15)Wang L, Zhang B, Li M, Li C, Liu J, Liu Y, et al. Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals. Hypertens Res. 2014;37(12):1068. doi: 10.1038/hr.2014.124, PMid: 25099490 16)Maharjan S, Mopidevi B, Kaw MK, Puri N, Kumar A. Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression. Physiological genomics. 2014;46(24):860-5. doi: 10.1152/physiolgenomics.00084.2014, PMid: 25351194, PMCid: PMC4269658 17)Rajan S, Ramu P, Umamaheswaran G, Adithan C. Association of aldosterone synthase (CYP11B2 C-344T) gene polymorphism & susceptibility to essential hypertension in a south Indian Tamil population. Indian J Med Res. 2010;132(4):379-86. 18)Zhang H, Li X, Zhou L, Zhang K, Zhang Q, Li J, et al. A novel haplotype of low-frequency variants in the aldosterone synthase gene among northern Han Chinese with essential hypertension. Medicine. 2017;96(39). doi: 10.1097/MD.0000000000008150, PMid: 28953657, PMCid: PMC5626300 19)Asadpoor AA, Zarkani NJ. Sociological Analysis of the Immigration Consequences on the Social Distance of Citizens. Academic Journal of Psychological Studies. 2016;5(3):201-7. 20)do Prado‐Lima P, Chatkin J, Taufer M, Oliveira G, Silveira E, Neto C, et al. Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am J Med Genet Part B: Neuropsychiatric Genetics. 2004;128(1):90-3. doi: 10.1002/ajmg.b.30004, PMid: 15211639 21)Carey RM, Whelton PK. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. Ann Intern Med. 2018;168(5):351-8. doi: 10.7326/M17-3203, PMid: 29357392 22)Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142-61. doi: 10.1161/01.HYP.0000150859.47929.8e, PMid: 15611362 23)Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi: 10.1093/nar/16.3.1215, PMid: 3344216, PMCid: PMC334765 24)Nejatizadeh A, Kumar R, Stobdan T, Goyal A, Gupta M, Tyagi S, et al. CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension. Clin Biochem. 2010;43(1-2):136-41. doi: 10.1016/j.clinbiochem.2009.09.015, PMid: 19786005 25)Cheng X, Xu G. A systemic review of the relationship between aldosterone synthase–344 C/T polymorphism and hypertension in Han. Clin Exp Hypertens. 2010;32(5):301-7. doi: 10.3109/10641960903443509, PMid: 20662731 26)Sookoian S, Gianotti TF, Gonzalez CD, Pirola CJ. Association of the C− 344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens. 2007;25(1):5-13. doi: 10.1097/01.hjh.0000254372.88488.a9, PMid: 17143166 27)Nicod Jrm, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P. A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. The Journal of J ClinEndocrinol Metab. 2003;88(6):2495-500. doi: 10.1210/jc.2002-021598, PMid: 12788845 28)Young Jr W. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285(2):126-48. doi: 10.1111/joim.12831, PMid: 30255616

Downloads

Published

2021-12-11